Argatroban
Back to searchMolecule Structure
Scientific Name
Argatroban
Description of the Drug
Argatroban is a synthetic direct thrombin inhibitor used for the prevention and treatment of thrombosis related to heparin use.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00278
http://www.drugbank.ca/drugs/DB00278
Brand Name(s)
Acova, Argatroban, Argatroban in dextrose, Argatroban in sodium chloride
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Cipla Ltd, Fresenius Kabi Usa Llc, Sandoz Inc, Hospira Inc, Par Sterile Products Llc, Caplin Steriles Ltd, Hikma Pharm Co Ltd, Gland Pharma Ltd, Eugia Pharma Specialities Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thrombin | SINGLE PROTEIN | INHIBITOR | CHEMBL204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1145308 | SCHEMBL20567702 |
| DrugBank | DB00278 | |
| PubChem: Thomson Pharma | 14786818 | 14786817 |
| PubChem | 92722 | |
| LINCS | LSM-5061 | |
| Nikkaji | J69.894F | |
| BindingDB | 50038001 | |
| DrugCentral | 239 | |
| Brenda | 8505 | |
| ChemicalBook | CB7738830 | CB12103951 |
| Guide to Pharmacology | 6385 | |
| rxnorm | ARGATROBAN ANHYDROUS | ARGATROBAN |
| ChEBI | 94385 |
